Androgen Receptor Signaling Pathway in Prostate Cancer: From Genetics to Clinical Applications

Around 80–90% of prostate cancer (PCa) cases are dependent on androgens at initial diagnosis; hence, androgen ablation therapy directed toward a reduction in serum androgens and the inhibition of androgen receptor (AR) is generally the first therapy adopted. However, the patient’s response to androg...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cells
Autori principali: Aurilio, Gaetano, Cimadamore, Alessia, Mazzucchelli, Roberta, Lopez-Beltran, Antonio, Verri, Elena, Scarpelli, Marina, Massari, Francesco, Cheng, Liang, Santoni, Matteo, Montironi, Rodolfo
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2020
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7763510/
https://ncbi.nlm.nih.gov/pubmed/33321757
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cells9122653
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi